We are live on
!
Find out more
WRM
Weybosset Research & Management Portfolio holdings
AUM
$347M
1-Year Est. Return
29.87%
This Fund
S&P 500
This Quarter
Est. Return
+4.53%
1 Year Est. Return
+29.87%
3 Year Est. Return
+64.94%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$174M
AUM Growth
+$8.06M
(+4.9%)
Cap. Flow
+$2.64M
Cap. Flow
% of AUM
1.52%
Top 10 Holdings %
Top 10 Hldgs %
51.49%
Holding
58
New
4
Increased
27
Reduced
8
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ingredion
INGR
|
+$952K |
| 2 |
Altria Group
MO
|
+$201K |
| 3 |
New York Times
NYT
|
+$197K |
| 4 |
GE Aerospace
GE
|
+$175K |
| 5 |
FMC
FMC
|
+$159K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$340K |
| 2 |
Netflix
NFLX
|
+$211K |
| 3 |
M&T Bank
MTB
|
+$206K |
| 4 |
Copart
CPRT
|
+$133K |
| 5 |
Apple
AAPL
|
+$44.2K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 30.88% |
| 2 | Financials | 15.21% |
| 3 | Technology | 12.55% |
| 4 | Consumer Discretionary | 12.02% |
| 5 | Healthcare | 10.85% |
Similar funds
WC
FFA
VW
GCP
MIG
PC
AWA
LAM
Weybosset Research & Management's Q3 2018 Portfolio in Review
As of Q3 2018, Weybosset Research & Management held 58 positions worth $174M, up 4.9% from $165M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Weybosset Research & Management's Q3 2018 filing shows 4 new, 27 increased, 8 reduced and 3 closed positions. Its largest new stake was Altria Group: 3,384 shares worth $204K. The largest sale was AbbVie, an estimated $340K.
By sector, the portfolio is most concentrated in Industrials at 31% of assets, up from 30% a quarter earlier, followed by Financials and Technology.
- Weybosset Research & Management's largest Q3 2018 buy was Altria Group: 3,384 shares worth $204K.
- Weybosset Research & Management added most to Ingredion in Q3 2018, an estimated $952K increase.
- Weybosset Research & Management's biggest Q3 2018 reduction was Copart, cutting an estimated $133K.
- Weybosset Research & Management fully exited AbbVie in Q3 2018, selling an estimated $340K.
- Weybosset Research & Management's ten largest holdings make up 51% of its $174M portfolio in Q3 2018.
- Weybosset Research & Management opened 4 new positions and closed 3 in Q3 2018.
- Weybosset Research & Management's portfolio value rose 4.9% quarter-over-quarter to $174M.
Based on Weybosset Research & Management's 13F filing for Q3 2018, filed 11 Oct 2018.